Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pain 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

X-Rays 2Platinum 2Magnetic Resonance Spectroscopy 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Cytoreduction Surgical Procedures 2Cisplatin 2Aspirin 21,2-diaminocyclohexaneplatinum II citrate 2talazoparib 1sodium thiosulfate 1propranolol CR 1pembrolizumab 1olaparib 1epacadostat 1adavosertib 1Taxes 1Specimen Handling 1Propranolol 1Paclitaxel 1Ketorolac Tromethamine 1Ketorolac 1Fluoresceins 1Fluorescein 1Doxorubicin 1Carboplatin 1Auranofin 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fallopian Tube Neoplasms × Ketorolac × Clear all
NCT01670799 2020-02-27

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

New Mexico Cancer Research Alliance

Phase EARLY_PHASE1 Completed
29 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡